Illumina Days Payables Outstanding from 2010 to 2024

ILMN Stock  USD 144.36  1.41  0.99%   
Illumina Days Payables Outstanding yearly trend continues to be very stable with very little volatility. Days Payables Outstanding is likely to drop to 39.80. During the period from 2010 to 2024, Illumina Days Payables Outstanding quarterly data regression pattern had sample variance of  262.90 and median of  66.34. View All Fundamentals
 
Days Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
50.80965909
Current Value
39.8
Quarterly Volatility
16.21415711
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Illumina financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Illumina's main balance sheet or income statement drivers, such as Depreciation And Amortization of 453.6 M, Interest Expense of 60.3 M or Total Revenue of 4.7 B, as well as many indicators such as Price To Sales Ratio of 4.51, Dividend Yield of 0.0 or PTB Ratio of 5.32. Illumina financial statements analysis is a perfect complement when working with Illumina Valuation or Volatility modules.
  
Check out the analysis of Illumina Correlation against competitors.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

Latest Illumina's Days Payables Outstanding Growth Pattern

Below is the plot of the Days Payables Outstanding of Illumina over the last few years. It is Illumina's Days Payables Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Illumina's overall financial position and show how it may be relating to other accounts over time.
Days Payables Outstanding10 Years Trend
Slightly volatile
   Days Payables Outstanding   
       Timeline  

Illumina Days Payables Outstanding Regression Statistics

Arithmetic Mean66.55
Geometric Mean64.95
Coefficient Of Variation24.36
Mean Deviation8.15
Median66.34
Standard Deviation16.21
Sample Variance262.90
Range76.5604
R-Value(0.57)
Mean Square Error189.73
R-Squared0.33
Significance0.03
Slope(2.08)
Total Sum of Squares3,681

Illumina Days Payables Outstanding History

2024 39.8
2023 50.81
2018 66.34
2017 63.07
2012 68.82
2011 52.47
2010 116.36

About Illumina Financial Statements

Illumina investors utilize fundamental indicators, such as Days Payables Outstanding, to predict how Illumina Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Days Payables Outstanding 50.81  39.80 

Pair Trading with Illumina

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.

Moving together with Illumina Stock

  0.74DRUG Bright Minds BiosciencesPairCorr

Moving against Illumina Stock

  0.77FDMT 4D Molecular TherapeuticsPairCorr
  0.65MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.63ICU LMF Acquisition OppoPairCorr
  0.5VALN Valneva SE ADRPairCorr
  0.48VRAX Virax Biolabs GroupPairCorr
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Check out the analysis of Illumina Correlation against competitors.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
(9.97)
Revenue Per Share
27.654
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0262
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.